Skip to main content
Search

RESTORE: Re-do TAVR for TAVR Failure

RESTORE Study (REdo tranScatheter aortic valve replacement for Transcatheter aOrtic valve failuRE)

  • Clinical Trial Information

    Trial Contact: Ngo, George M.; Harms, Gabrielle T; Marquart, Vashnie; Rodriguez, Jessica M

    Trial Phone: 3218439657 ; 4077012135 ; 321-843-1037 ; 3218413270

  • IRB No: S25.022.01

    Protocol Abbrev: RESTORE

    Principal Investigator:

    Age Group: Adult

    Secondary Protocol No: MDT23040EVR015- Version 2.0

    Treatment: Redo TAVR for the treatment of BVF affecting TAVs

    Therapies Involved: Procedural

    ClinicalTrials.gov ID: NCT06557798

  • Objective

    To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs
    To determine the factors which are associated with the acute and long-term outcomes of redo TAVR

  • Key Eligibility

    Subjects with symptomatic heart disease due to bioprosthetic valve failure (BVF) affecting TAVs and requiring redo Transcatheter Aortic Valve Replacement (TAVR). All devices in this study will be used per the intended use approved by the local regulatory agency.

Share:

Related Trials